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Abstract: 
 
98 Background: The association between air pollution and rhinitis is not well established. 
 
99 Aim: The aim of this longitudinal analysis was to study the association between modeled air 
 
100 pollution at the subjects’ home addresses and self-reported incidence of rhinitis. 
 
101 Methods: We used data from 1533 adults from two multicentre cohorts’ studies (EGEA and 
 
102 ECRHS). Rhinitis incidence was defined as reporting rhinitis at the second follow-up (2011 to 
 
103 2013) but not at the first follow-up (2000 to 2007). Annual exposure to NO2, PM10 and PM2.5 
 
104 at the participants’ home addresses was estimated using land-use regression models developed 
 
105 by the ESCAPE project for the 2009-2010 period. Incidence rate ratios (IRR) were computed 
 
106 using Poisson regression. Pooled analysis, analyses by city and meta-regression testing for 
 
107 heterogeneity were carried out. 
 
108 Results: No association between long-term air pollution exposure and incidence of rhinitis 
 
109 was found (adjusted IRR (aIRR) for an increase of 10 g.m−3 of NO2: 1.00[0.91-1.09], for an 
 
110 increase of 5g.m−3 of PM2.5: 0.88[0.73-1.04]). Similar results were found in the two- 
 
111 pollutant model (aIRR for an increase of 10 g.m−3 of NO2: 1.01[0.87-1.17], for an increase of 
 
112 5g.m−3 of PM2.5: 0.87[0.68-1.08]). Results differed depending on the city, but no regional 
 
113 pattern emerged for any of the pollutants. 
 
114 Conclusions: This study did not find any consistent evidence of an association between long- 
 
115 term air pollution and incident rhinitis. 
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116 Introduction: 
 
117 The prevalence of rhinitis varies between 10 and 50% worldwide (Bousquet et al. 2008; Wang 
 
118 et al. 2014) and has strongly increased during the last decades, mostly in industrialized 
 
119 countries (de Marco et al. 2012; Zhang and Zhang 2014). Although rhinitis is usually 
 
120 considered as a minor respiratory condition, it is often associated with a strong impairment in 
 
121 daily life and has an important economical and societal impact (Bousquet et al. 2017; 
 
122 Leynaert and Soussan 2003; Linneberg et al. 2016). Although environmental determinants of 
 
123 rhinitis are not well-known, environmental changes are suspected to be a major driver in the 
 
124 rise of allergy. During the past years, the link between outdoor air pollution and allergy 
 
125 continues to strengthen, both in children and in adults (Carlsten and Rider 2017). 
 
 
126 Rhinitis is a complex disease, frequently associated with asthma, whatever the allergic 
 
127 sensitization status (Shaaban et al. 2008). In adults there is growing evidence associating air 
 
128 pollution with asthma (Guarnieri and Balmes 2014). There are also evidences of the adverse 
 
129 effect of outdoor air pollution on allergic diseases (HEI 2010; Heinrich and Wichmann 2004), 
 
130 even if this association is not consistently reported (Lindgren et al. 2009). However, there are 
 
131 very few studies on the effect of air pollution on rhinitis (Deng et al. 2016; Jang et al. 2016; 
 
132 Rancière et al. 2016). It has been shown that air pollution and particularly diesel exhaust 
 
133 particles have the capability of enhancing immunological responses to allergens and elicit 
 
134 inflammatory reactions in the airways at relatively low concentrations and even with short 
 
135 exposure durations (Brunekreef and Sunyer 2003). Traffic-related air pollutants modify 
 
136 responses to allergens in the nasal mucosa (Peden 2001), and several studies have shown an 
 
137 increase in daily consultations for allergic rhinitis in general practitioners due to short-term air 
 
138 pollution exposure (Hajat et al. 2001; Zhang et al. 2011). Traffic-related air pollution has been 
 
139 consistently associated with prevalence of rhinitis among an Italian population, but only 
 
140 among non-smokers (Cesaroni et al. 2008). Furthermore, proximity to traffic has been 
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141 associated with allergic rhinitis prevalence among Swedish adults (Lindgren et al. 2009). 
 
142 However, no study has ever assessed the association between exposure to long-term air 
 
143 pollution and the incidence of rhinitis in adults. 
 
 
144 The aim of the present study was to assess the association between long term modeled air 
 
145 pollution exposure at the participant’s home addresses and the incidence of self-reported 
 
146 rhinitis among adults from two large European studies. 
 
 
 
147 Methods: 
 
148 Study design and participants 
 
 
149 The data came from two multicentre epidemiological European studies: the French 
 
150 Epidemiological case-control and family-based study of the Genetics and Environment of 
 
151 Asthma (EGEA, (Kauffmann et al. 1997)), and the population-based study: the European 
 
152 Community Respiratory Health Survey (ECRHS, (Burney et al. 1994)). 
 
 
153 EGEA is a cohort study based on an initial group of asthma cases recruited in chest clinics 
 
154 between 1991 and 1995 from 5 French cities (EGEA1, https://egeanet.vjf.inserm.fr/) along 
 
155 with their first-degree relatives, and a group of controls (n=2,047). A first follow-up (EGEA2, 
 
156 (Kauffmann 1999; Kauffmann et al. 1997)) was conducted between 2003 and 2007 (n=2121) 
 
157 and a second follow-up (EGEA3) between 2011 and 2013 using self-completed questionnaire 
 
158 (n=1558) (Bouzigon et al. 2015). 
 
 
159 ECRHS is a random population-based multicentre cohort of young adults, aged 20 to 44 years 
 
160 at recruitment, enriched with participants with respiratory symptoms, recruited from 1992 to 
 
161 1994 in 28 western European cities (ECRHS I, n=17880 http://www.ecrhs.org/) and followed 
 
162 up twice: between 2000 and 2002 (ECRHS II, n=10933 (Jarvis 2002; Kogevinas et al. 2007)) 
 
163 and between 2011 and 2013 (ECRHS III, n=7040). 
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164 Both cohort studies applied standardized protocols and comparable detailed questionnaires on 
 
165 respiratory health and risk factors for the two follow-up. Ethical approval was obtained in 
 
166 each cohort from the appropriate institutional ethics committees, and written consent was 
 
167 obtained from each participant. 
 
 
168 The present longitudinal analysis includes a subsample of 1533 adults from 17 European 
 
169 cities who reported no rhinitis at the first follow-up (EGEA2, ECRHS II), and with available 
 
170 data on rhinitis and air pollution exposure at the second follow up (EGEA3, ECRHS III, 
 
171 Figure 1). 
 
 
172  
 
 
173 Figure 1 Flow-chart of the participants 
 
174 Estimation of air pollution exposure 
 
 
175 Within the frame of the European Study of Cohorts for Air Pollution Effects (ESCAPE 
 
176 www.escapeproject.eu (Beelen et al. 2013; Eeftens et al. 2012)), the place of residence of 
 
177 each subject at the first follow-up of the two studies (EGEA2 and ECRHS II) was geocoded 
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178 and linked with NO2 (nitrogen dioxide), PM10 (airborne particles with an aerodynamical 
 
179 diameter ≤10 µm) and PM2.5 (airborne particles with an aerodynamical diameter ≤25 µm) 
 
180 model estimates developed between 2009 and 2010. Estimates of NO2 are available for 17 
 
181 cities (Umea, Norwich, Ipswich, Antwerp, Erfurt, Paris, Lyon, Grenoble, Marseille, Verona, 
 
182 Pavia, Turin, Oviedo, Galdakao, Barcelona, Albacete and Huelva). Given that PM were 
 
183 measured only in a subset of cities within ESCAPE, estimates of PM were available for 6 
 
184 cities (Norwich, Ipswich, Antwerp, Paris, Grenoble, Turin and Barcelona). Annual averages 
 
185 of air pollutant concentrations were estimated at participants’ residential addresses with land 
 
186 use regression models. Results are reported for an increase of 10 g.m−3 for PM10 and NO2 
 
187 and 5 g.m−3 for PM2.5, following the ESCAPE protocol (Beelen et al. 2014). Assessment of 
 
188 air pollution exposure is detailed in the Supplementary material. 
 
 
189 The main results for estimates of NOx (nitrogen oxides), PM2.5absorbance, PMcoarse and two 
 
190 traffic exposure indicators - traffic intensity (on the nearest road), and traffic load (in a 100m 
 
191 buffer) - are available in the supplementary material. 
 
 
192 Definition of rhinitis, asthma and allergic sensitization 
 
 
193 Rhinitis was defined by a positive response to “Have you ever had a problem with sneezing, 
 
194 or a runny or a blocked nose when you did not have a cold or the flu?” in EGEA and ECRHS. 
 
195 Incident rhinitis was defined by a positive response at EGEA3/ECRHS III and a negative 
 
196 response at EGEA 2/ECRHS II. This definition does not distinguish between rhinitis 
 
197 subtypes; to differentiate between participants with nonallergic rhinitis and those with allergic 
 
198 rhinitis, stratified analyses by allergic sensitization were used. In order to ensure that incident 
 
199 cases were real incident cases of rhinitis, several steps of caution were taken: 1) participants 
 
200 that have declared nasal symptoms (EGEA1) or nasal allergy (ECRHS I) at inclusion were 
 
201 excluded, 2) participants with a positive response to “Have you ever had allergic rhinitis?” or 
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202 “Have you ever had hay fever?” at EGEA2 or ECRHS II were not considered in the analysis, 
 
203 3) participants with no rhinitis at both first (EGEA2 or ECRHS II ) and second follow-up 
 
204 (EGEA3 or ECRHS III ) but who had answered yes to “Have you ever had allergic rhinitis?” 
 
205 or “Have you ever had hay fever?” at EGEA3 or ECRHS III were also excluded from the 
 
206 analyses. In a sensitivity analysis, incidence of allergic rhinitis, defined by a positive response 
 
207 to “Have you ever had allergic rhinitis?” or “Have you ever had hay fever?” was considered. 
 
 
208 “Asthma ever” was defined (Siroux et al. 2011) by a positive response to “Have you ever had 
 
209 asthma?” in ECRHS; and by a positive response to one of the following questions “Have you 
 
210 ever had attacks of breathlessness at rest with wheezing?” or “Have you ever had asthma 
 
211 attacks?” or by being recruited as an asthmatic case in EGEA. 
 
 
212 Allergic sensitization was defined using the skin-prick test (SPT) for 12 aeroallergens in 
 
213 EGEA2 (a wheal diameter ≥3 mm and superior to the negative control wheal to at least one of 
 
 
214 the allergen among: cat, Dermatophagoides pteronyssinus, Blattela germanica, olive, 
 
215 birch, Parieteria judaica, timothy grass, ragweed pollen, Aspergillus, Cladosporium 
 
216 herbarum, Alternaria tenuis). Allergic sensitization was defined using specific 
 
217 Immunoglobulin E (IgE) to four allergens in ECRHS II (specific IgE≥35kU/ml to at least one 
 
 
218 of the allergen among: cat, Dermatophagoides pteronyssinus, Cladosporium, and timothy 
 
219 grass). 
 
 
220 Statistical analysis 
 
 
221 The differences in general characteristics between the two studies were evaluated using the 
 
222 Student test for quantitative variables and the Chi-square test or Fisher exact test for 
 
223 qualitative variables. 
 
 
224 Incident rates of rhinitis were estimated as the ratio between the number of new cases at 
 
225 ECRHS III/EGEA3 and the number of person-years at risk (per 1,000), which were 
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226 considered to be equal to the length of the follow-up (between ECRHS II/EGEA2 and 
 
227 ECRHS III/EGEA3) (De Marco et al. 2011) for each participant of the cohort who was 
 
228 rhinitis-free at baseline. Exact 95% confidence intervals were computed using the Poisson 
 
229 distribution. Correlations between pollutants were assessed using the Spearman coefficient. 
 
 
230 Associations between air pollutants and incident rhinitis were evaluated using incidence rate 
 
231 ratio (IRR) in a pooled dataset. The IRRs were computed using Poisson regression models, 
 
232 with a random-intercept at city level (level 2), and the follow-up time as an offset. Based on 
 
233 the ESCAPE protocol, estimates were calculated for an increase of 10 μg/m3 for NO2 and 
 
234 PM10, 5 μg/m3 for PM2.5 and PMcoarse, 10 μg/m3 for NOX, 4,000,000 vehicles*m/day for 
 
235 traffic load on all major roads in a 100m buffer and 5,000 vehicles/day for traffic density on 
 
236 the nearest road. The estimates were adjusted for pre-selected variables -at ECRHS II/ 
 
237 EGEA2- based on previous literature: age, sex, number of siblings, family history of allergy, 
 
238 smoking status, educational level -as a proxy of socio-economic status- and asthma status. 
 
239 Analyses with traffic density or traffic load were also adjusted for NO2 background level. In a 
 
240 sensitivity analysis, the fully adjusted model was additionally adjusted for study 
 
241 (EGEA/ECRHS). Analyses were subsequently stratified according to pre-set subgroups, 
 
242 namely asthma status, allergic sensitization status, sex, smoking, and finally study 
 
243 (EGEA/ECRHS) because of the different recruitment criteria in EGEA and ECRHS. 
 
 
244 In a second step, analysis by city and meta-regression were applied to study the association 
 
245 between air pollution and incident rhinitis for each city. The DerSimonian-Laird approach 
 
246 was used to estimate the between-study variance and heterogeneity was measured by I2, 
 
247 which ranges from 0% to 100%. The I² statistic describes the percentage of variation across 
 
248 studies that is due to heterogeneity rather than chance (Higgins and Thompson 2002; Higgins 
 
249 et al. 2003). These meta-regressions were adjusted only for age as the number of incident 
 
250 cases was too small in some cities to adjust for other factors. 
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251 Analyses were done using R statistical software (R Core Team, 2012). 
 
 
252 Results: 
 
253 A total of 1533 adults from 17 European cities (Table 1) were included in the analyses: 1358 
 
254 from ECRHS (mean age=43.3 years, 51.4% female) and 175 from EGEA (mean age=44.4 
 
255 years, 49.7% female). The crude incident rate at the 3rd follow-up was 23.4 per 1000 person- 
 
256 years (95% CI: [21.2-25.8]) with 394 participants reporting incident rhinitis and a median 
 
257 length of the follow-up of 11 years. Participants with incident rhinitis were younger and 
 
258 reported more often a history of asthma than those without rhinitis (Table 1). 
 
 
 
Variables 
All 
(N=1533) 
No rhinitis 
(N=1139) 
Incident 
rhinitis 
(N=394) 
p crude 
overall 
Age, mean±sd 43.4±8.9 43.7±8.9 42.7±8.9 0.06 
 (N=1533)    
Study, % EGEA 11.4 (N=1533) 11.4 11.4 1 
Sex=women 51.2 (N=1533) 50.1 54.3 0.17 
BMI, % (N=1374)   0.27 
<18 1.8 2.0 1.4  
18-25 49.6 48.1 54.1  
25-30 34.2 35.2 31.4  
>=30 14.3 14.7 13.2  
Smoking status, % (N=1520)   0.34 
current 30.7 29.7 33.7  
ex-smoker 27.8 28.2 26.5  
never 41.5 42.1 39.8  
Educational level, % (N=1529)   0.49 
low 26.3 26.8 24.7  
medium 34.7 34.9 33.8  
high 39.0 38.2 41.5  
Asthma ever, % 5.1 (N=1533) 4.1 7.9 <0.01 
Asthma age of onset, 17.8±16.2 (N=75) 18.6±16.9 16.7±15.4 0.61 
mean±sd     
Report of hay fever or AR 5.6 (N=1522) 0 22.2 <0.01 
ever, %     
Allergic sensitization, % 18.4 (N=1306) 17.6 22.2 0.25 
NO2,  g.m−3, mean±sd* 29.3±15.1 
(N=1533) 
28.9±15.4 30.3±14.2 0.11 
PM10,  g.m−3, mean±sd* 26.9±8.3 (N=738) 27.2±8.7 26.2±7.1 0.09 
PM2.5,  g.m−3, mean±sd* 16.4±4.9 (N=738) 16.6±5.2 15.9±4.4 0.08 
*Annual.averaged     
259 Table 1 General characteristics of all the participants at ECRHS II/EGEA2, and according to rhinitis status 
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260 Correlations between the three pollutants were high (0.71 between NO2 and PM10, 0.70 
 
261 between NO2 and PM2.5 and 0.77 between PM10 and PM2.5, Table 1 in Supplementary 
 
262 material). 
 
 
263 Main analysis 
 
 
264 Pooled analyses of the associations between NO2, PM10 or PM2.5 and incident rhinitis showed 
 
265 no statistically significant results (Table 2). In a two-pollutant model including NO2 and 
 
266 PM2.5, results were very similar to those of the single pollutant-model. No association was 
 
267 found when considering other pollutants or traffic measures (NOx, PM2.5 absorbance, PM 
 
268 coarse or traffic measures, Supplemental Material, Table 2). The sensitivity analysis studying 
 
269 incident allergic rhinitis showed similar results (Table 2). 
 
 
270 Stratifying by study 
 
 
271 When stratifying by study, estimates of the associations were positive in the EGEA study for 
 
272 the three air pollutants and statistically significant for NO2 in the crude analysis (Table 2). In 
 
273 the adjusted model, this estimate was similar and borderline. No statistically significant 
 
274 association was found in ECRHS, where results were similar to those from the main analysis. 
 
 
275 Stratifying by asthma status 
 
 
276 When stratifying by asthma status, estimates were positive in participants with asthma and 
 
277 similar to the main analysis in those without asthma for the three air pollutants. However, 
 
278 none of the results were statistically significant (Table 2). 
 
 
279 Stratifying by allergic sensitization status 
 
 
280 Among the sensitized participants, estimates were negative for PM10 and PM2.5. Results were 
 
281 statistically significant only for PM2.5 (Table 2). The strength of the associations increases in 
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282 the adjusted model. Among non-sensitized participants, no statistically significant association 
 
283 was found with any of the three pollutants. 
 
 
284 Stratifying by sex 
 
 
285 Among males only, estimates were negative for PM10 and PM2.5 and statistically significant 
 
286 only for PM2.5 (Table 2). No statistically significant association was found among females or 
 
287 with NO2. 
 
 
288 Stratifying by smoking status 
 
 
289 Finally, when stratifying by smoking status, a borderline positive association of rhinitis with 
 
290 NO2 was found among non-smokers, while an inverse significant relationship was found with 
 
291 PM10 among smokers (Table 2). 
 
 
292 Additionally, adjusting the results for study did not change any of the results (data not 
 
293 shown). 
 
 
294 Analysis by city and meta-regression 
 
 
295 Estimates for NO2 were positive in 8 out of 17 cities but reached statistical significance only 
 
296 in Paris. Estimates were negative in 9 cities but not statistically significant (Figure 2). 
 
297 Similarly, positive and negative estimates were found according to the city for PM10 and 
 
298 PM2.5. However, no statistical heterogeneity between cities was found in the meta-regression, 
 
299 with I2 values ranging from 0% for PM2.5 to 36% for PM10. No significant association was 
 
300 found in the meta-regressions (Figure 2). 
 
 
301 A sensitivity analysis considering participants separately from EGEA and ECRHS, and from 
 
302 Grenoble and Paris, showed that among the same city, results differed according to the study 
 
303 (Figure 1 in Online Repository) 
 Main analyses 
Two-pollutant model (NO2, PM2.5) 
1372(354) 645(187) 1.02[0.93-1.11] 0.90[0. 
1.05[0.91-1.21] 
73-1.10] 0.89[0.73-1.05] 1.00[0.91-1.09] 0.88[0.72-1.08] 0.88[0.73-1.04] 
0.84[0.66-1.05] 1.01[0.87-1.17] 0.87[0.68-1.08] 
Stratified analyses   
By study 
EGEA 
 
 
112(30) 
** 
80(21) 1.42[1.12-1.82] 1.77[0.67-4.35] 1.82[0.73-4.88] 1.38[0.99-2.06] 
 
 
2.57[0.54-10.2] 
 
 
2.22[0.55-9.14] 
ECRHS 1260(324) 565(166) 0.98[0.89-1.07] 0.88[0.71-1.08] 0.87[0.70-1.03] 0.98[0.89-1.07] 0.87[0.70-1.08] 0.87[0.71-1.04] 
By asthma status 
Asthmatics 
 
 
65(25) 
 
40(16) 1.16[0.94-1.39] 0.98[0.55-1.60] 0.90[0.51-1.43] 1.09[0.84-1.39] 
 
1.15[0.54-2.22] 
 
1.11[0.55-2.13] 
Non-asthmatics 1307(329) 605(171) 1.00[0.91-1.09] 0.89[0.71-1.10] 0.89[0.72-1.07] 0.99[0.90-1.08] 0.86[0.69-1.07] 0.87[0.71-1.04] 
 
Male 659(159) 304(82) 
Female 713(195) 341(105) 
 
      
llergic sensitization status 
0.96[0.81-1.12] 0.76[0.49-1.11] 0.66[0.35-0.95] 0.95[0.77-1.14] 0.73[0.42-1.15] 0.52[0.29-0.87] 
1.05[0.95-1.15] 0.93[0.76-1.17] 0.95[0.79-1.14] 1.05[0.95-1.15] 0.90[0.72-1.15] 0.93[0.76-1.14] 
moking status * 
smoker 803(212] 364(106) 0.98[0.88-1.09] 0.79[0.60-1.05] 0.83[0.62-1.07] 0.96[0.85-1.07] 0.75[0.56-0.99] 0.80[0.60-1.03] 
non-smoker 569(142] 281(81) 1.09[0.99-1.20] 1.03[0.80-1.31] 0.96[0.77-1.16] 1.10[0.99-1.22] 1.10[0.84-1.41] 0.99[0.78-1.22] 
 
 
No of subjects (No of 
incident cases) in 
  adjusted model   crude IRR  (95%CI)   aIRR (95%CI)   
PM10  and 
  Analyses NO2 PM2.5 NO2 PM10 PM2.5 NO2 PM10 PM2.5   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
By a 
atopic 202(59) 112(37) 
non-atopic 962(250) 442(132) 
By s 
 
 
 
By gender 
1.01[0.90-1.11] 0.83[0.63-1.07] 0.78[0.61-0.98] 0.99[0.88-1.10] 0.83[0.61-1.08] 0.76[0.57-0.98] 
1.04[0.93-1.17] 0.95[0.70-1.28] 0.98[0.75-1.26] 1.04[0.92-1.16] 0.92[0.68-1.24] 0.96[0.74-1.25] 
Secondary analysis 
Incidence of allergic rhinitis 1128 530 1.09[0.94-1.25] 0.91[0.70-1.17] 0.92[0.73-1.13] 1.07[0.92-1.23] 0.95[0.72-1.26] 0.94[0.73-1.17] 
aIRRR : Incidence Rate Ratio adjusted for age, sex, number of siblings, family history of allergy, smoking status, educational level and asthma status. IRR with duration of follow-up 
as offset and a random intercept at city level ,for an increase of 10 g.m−3 for NO2 and PM10 and for an increase of 5 g.m−3 for PM2.5. **: p-interaction= 0.047, *: p-interaction=0.08, 
all other p-interaction>0.12. 
304 Table 2 IRR of the associations between pollutants (NO2, PM10, PM2.5) and incident rhinitis, in all, and stratifying by study, asthma status, allergic sensitization and smoking 
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Figure 2 Association between NO2, PM10 and PM2.5 and incident rhinitis by city and meta-regression 
17  
Discussion 
 
In this longitudinal analysis of two multicentre cohorts’ studies, we could not observe any 
clear or consistent association between modeled annual average residential exposure to air 
pollution and incident rhinitis. In stratified analyses, exposure to PM2.5 was associated with 
smaller risk of rhinitis among participants with allergic sensitization and among males. 
Our results are difficult to compare with the literature as our study is the first to have 
investigated the association between long-term air pollution and incident rhinitis in adults. 
However, our reported overall null findings reported are in line with the literature in children 
where results are mixed according to the age, the window of exposure and the pollutant (Deng 
et al. 2016; Jang et al. 2016; Rancière et al. 2016). It is also worthy to note that our incident 
rate of rhinitis may seem high at first glance. However, there is little information on rhinitis 
incidence in adults in the literature, and the inclusion criteria of our analysis combined with a 
population enriched in asthmatics cases could explain this high rate. We showed that the 
strength and direction of the associations between air pollutants and incident rhinitis differed 
across the 17 European cities and also according to the study: an increase in NO2 being 
associated with rhinitis incidence among participants in EGEA but not in ECRHS. This result 
could be due to the fact that there are more cities included in ECRHS and given that air 
pollution strongly differs according to the city, air pollution also varies a lot according to the 
study. However, when looking at Paris and Grenoble, included in both EGEA and ECRHS, 
results strongly differ according to the study in the same city. Thus, it seems that there is a 
study effect which could be explained by the higher prevalence of asthmatics in the EGEA 
study due to its recruitment specificity. Indeed, when adjusting for asthma status, no 
statistically significant results appear but the effect of air pollution exposure on rhinitis 
incidence was increased among participants with asthma compared to those without asthma. 
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In stratified analyses, we found that PM exposure was negatively associated with incidence of 
rhinitis in some groups, even if there were no significant interactions. Due to the lack of 
studies on air pollution and incident rhinitis in adults, we have compared our results with 
literature in children and with studies on the association between air pollution and prevalence 
of rhinitis. We found that exposure to PM2.5 was negatively associated with incident rhinitis 
among males, and no effect was found among females. In a study on the association between 
proximity to traffic and prevalence of rhinitis in a Swedish population, no differences 
according to sex were found (Lindgren et al. 2009). Our results are also discordant with the 
paper by Deng who found a significant risk effect of early life exposure to traffic-related air 
pollutants and development of allergic rhinitis in males and with other studies in children 
discussed in the same paper (Deng et al. 2016). However, regarding rhinitis more broadly, a 
male predominance in childhood for allergic rhinitis has been shown in some studies (Alm et 
al. 2011) whereas there is no clear sex ratio among adults, although there might be a possible 
higher risk of non-allergic rhinitis among females (Cazzoletti et al. 2015). In our study, 
stratifying by smoking status gave discordant results according to air pollutant: a higher 
exposure to NO2 was associated with a non-significant increase in incident rhinitis among 
non-smokers whereas a higher exposure to PM10 was negatively and significantly associated 
with incident rhinitis among smokers. Among Italian adults, Cesaroni et al. (Cesaroni et al. 
2008) showed a positive association between an index of traffic exposure related to air 
pollution - based on self-report of traffic intensity, distance to busy road, concentrations of 
PM and NO2 - and prevalence of rhinitis among non-smokers only. Our results are thus not 
concordant for PM10 but concordant for NO2, a good marker of traffic and therefore more 
comparable to the index of traffic exposure related to air pollution used by Cesaroni et al. 
Rhinitis is a complex phenotype, often associated with asthma and/or allergic sensitization. 
Based on this fact and on literature showing a possible effect of allergic sensitization in the 
19  
association between air pollution and rhinitis or asthma (Burte et al. 2016; Lindgren et al. 
2009), we stratified our results by allergic sensitization to obtain results for allergic rhinitis 
and nonallergic rhinitis separately. We found that a higher exposure to air pollutants was 
negatively associated with incident rhinitis among sensitized participants (allergic rhinitis). 
This is discordant with the study by Lindgren et al. who found a positive association between 
air pollution and prevalence of allergic rhinitis, but not with rhinitis triggered by non-allergic 
factors. These discrepancies may be due to the fact that allergic sensitization was based on 
objective tests (SPT or specific IgE) in our analysis, whereas Lindgren et al. used self- 
reported triggers of rhinitis symptoms to distinguish between the two types of rhinitis. Our 
results also discord with several studies in children where exposure to air pollution has been 
associated to the development of allergic rhinitis (Brauer et al. 2007; Deng et al. 2016; 
Gehring et al. 2010). However, phenotypes of rhinitis are not the same in adults and in 
children (Izquierdo-Domínguez et al. 2013) and particularly regarding allergic rhinitis that is 
an integral part of the allergic march in children, but not in adults. The mechanisms 
explaining the differences in results according to allergic sensitization are unclear. However, 
the interaction between air pollution and allergens and particularly with pollen, further 
discussed below, is likely to play an important role. 
There are complex interactions between climate change, air pollution and allergens (Carlsten 
and Rider 2017; D’Amato et al. 2018; Reinmuth-Selzle et al. 2017), and in particular pollen 
(Annesi-Maesano et al. 2012). A study in Italy has shown that NO2 exposure was associated 
with an increase in allergic rhinitis prevalence, but only among participants living in the 
 
Mediterranean region, and not in the subcontinental one (de Marco et al. 2002). Data from our 
study came from 17 cities from all over Europe, reflecting different climates. However, we 
found no clear geographical pattern of the association between air pollution and rhinitis 
incidence when looking at each city separately. Climate is associated with air pollution levels 
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and may also act on the allergens by altering local and regional allergen production or by 
increasing the allergenicity of pollen (D’Amato et al. 2016; Sénéchal et al. 2015). Air 
pollution acts directly on pollen (D’Amato et al. 2007), and particles carrying pollen allergen 
molecules are likely to play a role in the association between air pollution and respiratory 
allergic diseases (Bono et al. 2016; Marchetti et al. 2017). Finally, the level of pollen 
exposure is associated to allergic rhinitis incidence and prevalence and has also been 
associated to severity of rhinitis (Annesi-Maesano et al. 2012). Unfortunately, data were not 
available on climate change or on allergen concentration. This would have helped to better 
understand our results, and particularly among those with allergic rhinitis for which allergen- 
pollution interaction may drive an important part of the association. In future studies, it will 
be important to consider these factors when studying air pollution exposure and allergic 
diseases, particularly hay fever. 
 
Socio-economic status may play a role in the relation between air pollution and respiratory 
symptoms and particularly asthma (Burte et al. 2016). However, in our study, adjusting for 
educational level did not change the results. Furthermore, the association between socio 
economic status and air pollution is not clearly established in Europe and is very 
heterogeneous according to the city (Temam et al. 2017). Similarly, our study, which also 
used data from ESCAPE, found results that varied considerably according to the city with no 
clear pattern. 
 
In our study, stratifying by allergic sensitization enabled us to distinguish results for allergic 
and nonallergic rhinitis but not for the other phenotypes of rhinitis, e.g mixed rhinitis 
(subjects having both allergic and nonallergic rhinitis). However, it is difficult to catch 
subjects with such phenotypes in epidemiological studies when allergy is based only on skin 
prick test or specific IgE. Another limitation of the present study is that despite the individual 
measure of air pollution, this measure was carried out using residential address and therefore 
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may not have taken into account the correct annual personal exposure of each participant. 
However, this is a limitation that often arises when dealing with long-term air pollution 
measurements. Another limitation is that analyses by city and meta-regression were adjusted 
only for age due to small sample size. Further adjustment would probably not have changed 
the results since in the general analysis adjusted results were similar to the crude analysis. 
However, results of the meta-regression have to be considered with caution because of the 
small sample size and the wide confidence intervals. For the same reason, results on the effect 
of PM exposure should also be considered with caution. 
The major strength of this study is that the population comes from two multicentric cohorts, 
followed for more than 20 years and including 17 European cities. Furthermore, there is a 
detailed characterization on respiratory phenotypes at both first and second follow-up as well 
as an individual measure of exposure to air pollution, obtained within the ESCAPE project. 
We were therefore able to perform a longitudinal analysis studying the long-term air pollution 
effect on incidence of rhinitis. Rhinitis definition is often based on the report of nasal allergy, 
hay fever or allergic rhinitis (de Marco et al. 2012; Smit et al. 2014). However, in our study 
we aimed to study the incidence of all types of rhinitis and not only the allergic subtypes. We 
therefore based our definition of rhinitis on nasal symptoms (Cazzoletti et al. 2015; Rancière 
et al. 2016). This choice also enabled the stratification of results by allergic sensitization and 
the possibility to distinguish the two types of rhinitis. Nevertheless, the definition of rhinitis is 
questionnaire-based and thus may not be as reliable as a physician diagnosis as it is often the 
case in epidemiological studies. 
The total air pollution exposure of an individual is not restricted to outdoor air pollution but is 
actually composed of a cocktail of pollutants, with both outdoor and indoor sources. The 
present study focused on the association between outdoor air pollution and rhinitis outcomes. 
Data on indoor air pollution exposures –which can be as harmful as the outdoor ones- were 
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not considered. Future studies should integrate both sources of pollution to give a more 
complete overview of the effects of air pollution on health. 
The inconsistent results may also reflect the fact that single factors – such as air pollution – 
may play a relevant role in the etiology of very complex multifactorial and often allergic 
diseases, mostly under multi-factorial interrelationships of many co-factors, among which 
climate change and allergen concentrations. This is consistent with the findings of the long- 
term association between air pollution and onset of asthma: inconsistent findings (Guarnieri 
and Balmes 2014) have also been reported and a more specific definition of traffic-related 
exposures such as typically encountered in high concentrations among those living very close 
to busy roads resulted in more consistent results. It will be interesting to investigate the role of 
air pollution in the development of rhinitis or other atopic diseases in countries with very high 
levels of air pollution but with very different patterns of possibly relevant etiologic co-factors. 
For example in low income countries with so far rather low prevalence of asthma or atopic 
diseases. 
Overall, no clear association was found between air pollution and incident rhinitis, whether in 
the main analysis, the bi-pollutant model or the stratified analysis. 
 
Conclusions: In this longitudinal study, we have analysed the effect of long-term exposure to 
air pollution on the incidence of rhinitis among 1533 adults, including 394 incident cases, 
from 17 European cities. We have found no clear association between long-term air pollution 
exposure and incident rhinitis. However, it could be interesting to look further into the 
association between air pollution and rhinitis, concentrating on the effect of air pollution on 
rhinitis phenotypes or rhinitis characteristics such as type of symptoms or severity. 
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